The leader proteinase of foot-and-mouth disease virus: Structure-function relationships in a proteolytic virulence factor

Biological Chemistry

Volumn 395, Issue 10, 2014, Pages 1179-1185

  Steinberger, Jutta ^a   Skern, Tim ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Deubiquitination; Initiation of protein synthesis; NF B inactivation; Papain like cysteine proteinase; Substrate specificity

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 4G; INTERFERON; MESSENGER RNA; PROTEINASE; VIRULENCE FACTOR; VIRUS RNA; MEMBRANE PROTEIN; PROTEIN SYNTHESIS INHIBITOR; SERINE PROTEINASE; TYPE I SIGNAL PEPTIDASE;

CONFERENCE PAPER; FOOT AND MOUTH DISEASE VIRUS; HOST; HOST CELL; HUMAN; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; VIRUS MORPHOLOGY; ANIMAL; CHEMICAL STRUCTURE; ENZYMOLOGY; GENETICS; METABOLISM; PROTEIN SECONDARY STRUCTURE;

EUKARYOTA; FOOT-AND-MOUTH DISEASE VIRUS;

ANIMALS; FOOT-AND-MOUTH DISEASE VIRUS; MEMBRANE PROTEINS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEIN SYNTHESIS INHIBITORS; SERINE ENDOPEPTIDASES; VIRULENCE FACTORS;

EID: 84926474776     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2014-0156     Document Type: Conference Paper

References (32)

1. Berti, P.J. and Storer, A.C. (1995). Alignment/phylogeny of the papain superfamily of cysteine proteases. J. Mol. Biol. 246, 273-283.
2. Brown, C.C., Piccone, M.E., Mason, P.W., McKenna, T.S., and Grubman, M.J. (1996). Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J. Virol. 70, 5638-5641.
3. Cao, X., Bergmann, I.E., Fullkrug, R., and Beck, E. (1995). Functional analysis of the two alternative translation initiation sites of foot-and-mouth disease virus. J. Virol. 69, 560-563.
4. Cencic, R., Mayer, C., Juliano, M.A., Juliano, L., Konrat, R., Kontaxis, G., and Skern, T. (2007). Investigating the substrate specificity and oligomerisation of the leader protease of foot and mouth disease virus using NMR. J. Mol. Biol. 373, 1071-1087.
5. Chinsangaram, J., Piccone, M.E., and Grubman, M.J. (1999). Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of ±/β interferon. J. Virol. 73, 9891-9898.
6. Crowder, S. and Kirkegaard, K. (2005). Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat. Genet. 37, 701-709.
7. de Los Santos, T., de Avila Botton, S., Weiblen, R., and Grubman, M.J. (2006). The leader proteinase of foot-and-mouth disease virus inhibits the induction of β-interferon mRNA and blocks the host innate immune response. J. Virol. 80, 1906-1914.
8. de Los Santos, T., Diaz-San Segundo, F., and Grubman, M.J. (2007). Degradation of nuclear factor κB during foot-and-mouth disease virus infection. J. Virol. 81, 12803-12815.
9. de los Santos, T., Segundo, F.D., Zhu, J., Koster, M., Dias, C.C., and Grubman, M.J. (2009). A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J. Virol. 83, 1800-1810.
10. Devaney, M.A., Vakharia, V.N., Lloyd, R.E., Ehrenfeld, E., and Grubman, M.J. (1988). Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62, 4407-4409.
11. Forss, S., Strebel, K., Beck, E., and Schaller, H. (1984). Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res. 12, 6587-6601.
12. Glaser, W., Cencic, R., and Skern, T. (2001). Foot-and-mouth disease Leader proteinase: involvement of C-terminal residues in self-processing and cleavage of eIF4GI. J. Biol. Chem. 276, 35473-35481.
13. Gradi, A., Foeger, N., Strong, R., Svitkin, Y.V., Sonenberg, N., Skern, T., and Belsham, G. (2004). Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: identification of the L-protease cleavage site in vitro. J. Virol. 78, 3271-3278.
14. Guarné, A., Hampoelz, B., Glaser, W., Carpena, X., Tormo, J., Fita, I., and Skern, T. (2000). Structural and biochemical features distinguish the foot-and-mouth disease virus leader proteinase from other papain-like enzymes. J. Mol. Biol. 302, 1227-1240.
15. Guarné, A., Tormo, J., Kirchweger, K., Pfistermueller, D., Fita, I., and Skern, T. (1998). Structure of the foot-and-mouth disease virus leader protease: a papain-like fold adapted for self-processing and eIF4G recognition. EMBO J. 17, 7469-7479.
16. Kirchweger, R., Ziegler, E., Lamphear, B.J., Waters, D., Liebig, H.D., Sommergruber, W., Sobrino, F., Hohenadl, C., Blaas, D., Rhoads, R.E., et al. (1994). Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J. Virol. 68, 5677-5684.
17. Kleina, L.G. and Grubman, M.J. (1992). Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. J. Virol. 66, 7168-7175.
18. Kuehnel, E., Cencic, R., Foeger, N., and Skern, T. (2004). Foot-and-mouth disease virus leader proteinase: specificity at the P2 and P3 positions and comparison with other papain-like enzymes. Biochemistry (Mosc). 43, 11482-11490.
19. Morley, S.J., Curtis, P.S., and Pain, V.M. (1997). eIF4G: translation's mystery factor begins to yield its secrets. RNA 3, 1085-1104.
20. Nogueira Santos, J.A., Assis, D.M., Gouvea, I.E., Judice, W.A., Izidoro, M.A., Juliano, M.A., Skern, T., and Juliano, L. (2012). Foot and mouth disease leader protease (Lbpro): Investigation of prime side specificity allows the synthesis of a potent inhibitor. Biochimie. 94, 711-718.
21. Petersen, J.F., Cherney, M.M., Liebig, H.D., Skern, T., Kuechler, E., and James, M.N. (1999). The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis. EMBO J. 18, 5463-5475.
22. Piccone, M.E., Rieder, E., Mason, P.W., and Grubman, M.J. (1995). The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 69, 5376-5382.
23. Pineiro, D., Ramajo, J., Bradrick, S.S., and Martinez-Salas, E. (2012). Gemin5 proteolysis reveals a novel motif to identify L protease targets. Nucleic Acids Res. 40, 4942-4953.
24. Sangar, D.V., Clark, R.P., Carroll, A.R., Rowlands, D.J., and Clarke, B.E. (1988). Modification of the leader protein (Lb) of foot-and-mouth disease virus. J. Gen. Virol. 69, 2327-2333.
25. Sangar, D.V., Newton, S.E., Rowlands, D.J., and Clarke, B.E. (1987). All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res. 15, 3305-3315.
26. Santos, J.A., Gouvea, I.E., Judice, W.A., Izidoro, M.A., Alves, F.M., Melo, R.L., Juliano, M.A., Skern, T., and Juliano, L. (2009). Hydrolytic properties and substrate specificity of the foot-and-mouth disease leader protease. Biochemistry (Mosc). 48, 7948-7958.
27. Skern, T., Fita, I., and Guarne, A. (1998). A structural model of picornavirus leader proteinases based on papain and bleomycin hydrolase. J. Gen. Virol. 79, 301-307.
28. Skern, T., Hampoelz, B., Guarné, A., Fita, I., Bergmann, E., Petersen, J., and James, M.N.G. (2002). Structure and function of picornavirus proteinases. In: Molecular Biology of Picornaviruses, B.L. Semler, and E. Wimmer, eds. (Washington, DC: ASM Press), pp. 199-212.
29. Steinberger, J., Kontaxis, G., Rancan, C., and Skern, T. (2013). Comparison of self-processing of foot-and-mouth disease virus leader proteinase and porcine reproductive and respiratory syndrome virus leader proteinase nsp1alpha. Virology 443, 271-277.
30. Strebel, K. and Beck, E. (1986). A second protease of foot-and mouth disease virus. J. Virol. 58, 893-899.
31. Sulea, T., Lindner, H.A., Purisima, E.O., and Menard, R. (2006). Binding site-based classification of coronaviral papain-like proteases. Proteins 62, 760-775.
32. Wang, D. Fang, L. Li, P. Sun, L. Fan, J. Zhang, Q. Luo, R. Liu, X. Li, K. Chen, H. et al. (2011). The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J. Virol. 85, 3758-3766